Technology

Based on the initial ophthalmic findings, it is difficult but important to predict the patients’ progression to a specific level of disease severity.

Step up your standard of care, free up office space, and exceed patient expectations by taking advantage of these tools.

A look back on what happened in optometry during the week ofMarch 27-March 31.

Technologies that improve treatment of ONHD and similar pathologies.

Lessons learned during 30 years in the industry.

Medical and surgical technological advances show promise for future glaucoma management.

Protecting children’s eye health will demand a focus on vision and learning through better nutrition, myopia management, and disease prevention.

Bausch + Lomb and Modulight announce the photodynamic laser for use with photodynamic therapy was approved by the FDA for the treatment of patients with subfoveal choroidal neovascularization due to AMD.

Individuals often have questions about their candidacy for certain implants and how the various mechanisms of action work.

IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying emergency department patients with sepsis and contribute to rapid life-saving decisions.

A look back on what's happened in optometry during the week of Jan. 1-Jan. 5, 2023.

Roland Mattern, director of marketing for eSight, illustrates the use of the company's eSight 4 device to assist patients with central vision loss.

Denise A. Valenti, OD, FAAO, gives key takeaways from her AAOpt 2022 discussion on the impact of marijuana use and driving.

Pinakin Davey, PhD, OD, FAAO, gives key highlights from his AAOpt 2022 presentation, "Management of digital eye strain: comprehensive strategy and nutritional approach."

When combined, intense pulsed light and low-level light therapy—both of which have roots in dermatology—create a synergistic effect that treat dry eye more effectively than one therapy alone.

Adam Ramsey, OD, shares key takeaways from his EyeCon 2022 presentation, "Advances in industry innovations to improve your practice."

The glaucoma field is on the move with significant innovations in a number of treatment areas. Experts discussed the various technologies at the Optometry Times 2022 EyeCon meeting in Marco Island, Florida.

As technology advances and choices grow, you need to personalize patients’ options.

Research indicates that too much technology usage results in negative effects on eyesight.

Brad Sutton, OD, FAAO, FORS, shares highlights from his discussion titled, "Retinal imaging grand rounds," which he co-presented during the 2022 American Academy of Optometry meeting.

Evolution of vision correction procedures, diagnostics paves way for collaborative care.

DigitalOptometrics President discusses the pioneering abilities of telemedicine and how the company is paving a new way for doctors to see patients of varying needs.

The web-based, self-guided software application is accessed through touchscreen mobile devices.

When considering the best modality these lenses' stability are superior.

As technology improves, less-invasive treatments save patients time and money.

Brandon Barber, chief marketing officer at Heru, shares about the company's new dark adaptation modality, which they announced during the 2022 Vision Expo West, as well as other advancements in the pipeline.

Valerie M. Kattouf, OD, discusses going back to the basics of neuro-ophthalmology + managing vision and visual-motor abnormalities in patients.

With the launch of dark adaptation, Heru is now the only platform on the AMD market to include contrast sensitivity and dark adaptation exams.

Low prediction errors from 2 evaluated formulas shows promise for accurate prediction of IOL formulas in high myopic patients.

Leo P. Semes, OD, FAAO, highlights his presentation on "Artificial intelligence and telemedicine," presented during the 115th annual SCOPA meeting.